A 60-day comment period opens on the information collection covering registration of human drug compounding outsourcing facilities and the fees associated with it.
Washington, 31 August 2026 — The Food and Drug Administration announced an opportunity for public comment on a proposed collection of information. The notice states that it solicits comments on the information collection relating to the registration of human drug compounding outsourcing facilities under the Federal Food, Drug, and Cosmetic Act and the fees associated with that registration.
Under the Paperwork Reduction Act of 1995, federal agencies must publish notice of each proposed collection of information, including each proposed extension of an existing collection, and allow 60 days for comment.
Source documents
-
Agency Information Collection Activities; Proposed Collection; Comment Request; Registration of Human Drug Compounding Outsourcing Facilities Under the Federal Food, Drug, and Cosmetic Act and Associated Fees
- Identifier
- Federal Register document 2026-17676
- As the record states
- The Food and Drug Administration (FDA or Agency) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on the information collection pertaining to the registration of human drug compounding outsourcing facilities under the Federal Food, Drug, and Cosmetic Act (FD&C Act) and associated fees.
- Document number
- 2026-17676